Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein

Citation:
Fathy, G. E., E. G. Abd-Ellatef, A. H. El-Desoky, A. R. Hamed, J. Kopecka, and S. R. Fahmy, "Glabratephrin reverses doxorubicin resistance in triple negative breast cancer by inhibiting P-glycoprotein", Pharmacological Research, vol. 157, pp. 105975, 2022.